With a House of Representatives vote Tuesday, Congress passed legislation that could give terminally ill patients a way to independently seek drugs that are still experimental and not fully approved by the US Food and Drug Administration.
Despite being lauded by some politicians (including subsequent to this story President Trump) this law is likely to concern most people involved in human research ethics (it certainly does concern us).
.
“This is an extraordinarily great day,” Democratic Sen. Joe Donnelly of Indiana, one of the original cosponsors of the bill, said in a press conference after the event. Donnelly said he met with Vice President Mike Pence a few weeks ago and urged him to push for a House vote on the bill.
.
